A research programme by the Access to Medicine Foundation
Member of the Expert Committee for the 2020 Antimicrobial Resistance Benchmark

Nina Grundmann

Nina Grundmann joined the IFPMA in June 2012. She leads IFPMA’s work on antimicrobial resistance and heads the secretariat of the AMR Industry Alliance, which represents more than 100 pharmaceutical companies. Nina has also worked on vaccine regulatory and programmatic policy and influenza vaccines.

Nina holds a master’s degree in International Affairs from the French Institute of Political Studies and a post-graduate degree in Risk Management from HEC Business School in Paris. Prior to joining IFPMA, Nina worked at Sanofi Pasteur on vaccination policy and advocacy and for the Mérieux Foundation to help enhance research capabilities in developing countries.


Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.